Skip to main content
. Author manuscript; available in PMC: 2016 May 11.
Published in final edited form as: J Health Econ. 2012 Dec 17;32(6):1313–1324. doi: 10.1016/j.jhealeco.2012.11.006

Table 7.

Multinomial logit models estimated with combined real and hypothetical choice data

(3) (4) (5)
Premium −0.0545***
(0.00429)		 −0.0647***
(0.00603)		 −0.0762***
(0.00600)
Insurance 1.416***
(0.187)		 1.378***
(0.240)		 0.980***
(0.229)
Insurance * Hypothetical 1.296***
(0.338)
No deductible 1.002***
(0.116)		 1.555***
(0.220)		 1.123***
(0.201)
No deductible * Hypothetical 0.574
(0.445)
Gap coverage (generics) 0.147
(0.190)		 0.0989
(0.197)		 0.184
(0.262)
Gap coverage (brand-name drugs) 0.754***
(0.104)		 1.163***
(0.292)		 1.565***
(0.392)
Gap coverage (brand-name) * Hypothetical −0.410
(0.451)
Drug tiers −1.372***
(0.121)		 −1.666***
(0.178)		 −0.927***
(0.217)
Top 100 drugs uncovered −0.136***
(0.0177)		 −0.119***
(0.0179)		 −0.109***
(0.0165)
Top 100 with authorization −0.104***
(0.0138)		 −0.0982***
(0.0153)		 −0.0789***
(0.0147)
Heteroskedasticity Parameter −0.762***
(0.237)		 −0.860***
(0.252)
Observations 22,997 22,997 22,997
Number of groups 1,613 1,613 1,613
log likelihood −2781 −2771 −2757

Robust standard errors in parentheses, SE are clustered by respondent

***

p<0.01,

**

p<0.05,

*

p<0.1